113 related articles for article (PubMed ID: 10348353)
1. Altered expression of the MYCN oncogene modulates MRP gene expression and response to cytotoxic drugs in neuroblastoma cells.
Haber M; Bordow SB; Gilbert J; Madafiglio J; Kavallaris M; Marshall GM; Mechetner EB; Fruehauf JP; Tee L; Cohn SL; Salwen H; Schmidt ML; Norris MD
Oncogene; 1999 Apr; 18(17):2777-82. PubMed ID: 10348353
[TBL] [Abstract][Full Text] [Related]
2. Reversal of multidrug resistance-associated protein-mediated drug resistance in cultured human neuroblastoma cells by the quinolone antibiotic difloxacin.
Norris MD; Madafiglio J; Gilbert J; Marshall GM; Haber M
Med Pediatr Oncol; 2001 Jan; 36(1):177-80. PubMed ID: 11464877
[TBL] [Abstract][Full Text] [Related]
3. Evidence that the MYCN oncogene regulates MRP gene expression in neuroblastoma.
Norris MD; Bordow SB; Haber PS; Marshall GM; Kavallaris M; Madafiglio J; Cohn SL; Salwen H; Schmidt ML; Hipfner DR; Cole SP; Deeley RG; Haber M
Eur J Cancer; 1997 Oct; 33(12):1911-6. PubMed ID: 9516823
[TBL] [Abstract][Full Text] [Related]
4. Expression of the gene for multidrug-resistance-associated protein and outcome in patients with neuroblastoma.
Norris MD; Bordow SB; Marshall GM; Haber PS; Cohn SL; Haber M
N Engl J Med; 1996 Jan; 334(4):231-8. PubMed ID: 8532000
[TBL] [Abstract][Full Text] [Related]
5. Expression of MRP and cMOAT in childhood neuroblastomas and malignant liver tumors and its relevance to clinical behavior.
Matsunaga T; Shirasawa H; Hishiki T; Enomoto H; Kouchi K; Ohtsuka Y; Iwai J; Yoshida H; Tanabe M; Kobayashi S; Asano T; Etoh T; Nishi Y; Ohnuma N
Jpn J Cancer Res; 1998 Dec; 89(12):1276-83. PubMed ID: 10081488
[TBL] [Abstract][Full Text] [Related]
6. Expression analysis of multidrug resistance associated genes in neuroblastomas.
Bader P; Schilling F; Schlaud M; Girgert R; Handgretinger R; Klingebiel T; Treuner J; Liu C; Niethammer D; Beck JF
Oncol Rep; 1999; 6(5):1143-6. PubMed ID: 10425316
[TBL] [Abstract][Full Text] [Related]
7. Targeted MYCN expression affects cytotoxic potential of chemotherapeutic drugs in neuroblastoma cells.
Paffhausen T; Schwab M; Westermann F
Cancer Lett; 2007 May; 250(1):17-24. PubMed ID: 17141950
[TBL] [Abstract][Full Text] [Related]
8. In vitro effects of MYCN sense and antisense expression in MYCN-amplified human neuroblastoma cells.
Kavallaris M; Gardaneh M; Cheung B; Camacho ML; Hocker JE; Norris MD; Haber M; Marshall GM
Anticancer Res; 1998; 18(3A):1793-7. PubMed ID: 9673406
[TBL] [Abstract][Full Text] [Related]
9. Expression of multidrug resistance-associated protein in NIH/3T3 cells confers multidrug resistance associated with increased drug efflux and altered intracellular drug distribution.
Breuninger LM; Paul S; Gaughan K; Miki T; Chan A; Aaronson SA; Kruh GD
Cancer Res; 1995 Nov; 55(22):5342-7. PubMed ID: 7585598
[TBL] [Abstract][Full Text] [Related]
10. Human neuroblastoma cells with MYCN amplification are selectively resistant to oxidative stress by transcriptionally up-regulating glutamate cysteine ligase.
Veas-Perez de Tudela M; Delgado-Esteban M; Cuende J; Bolaños JP; Almeida A
J Neurochem; 2010 May; 113(4):819-25. PubMed ID: 20180881
[TBL] [Abstract][Full Text] [Related]
11. Nitric oxide control of MYCN expression and multi drug resistance genes in tumours of neural origin.
Porro A; Chrochemore C; Cambuli F; Iraci N; Contestabile A; Perini G
Curr Pharm Des; 2010; 16(4):431-9. PubMed ID: 20236072
[TBL] [Abstract][Full Text] [Related]
12. Direct interaction between a quinoline derivative, MS-209, and multidrug resistance protein (MRP) in human gastric cancer cells.
Nakamura T; Oka M; Aizawa K; Soda H; Fukuda M; Terashi K; Ikeda K; Mizuta Y; Noguchi Y; Kimura Y; Tsuruo T; Kohno S
Biochem Biophys Res Commun; 1999 Feb; 255(3):618-24. PubMed ID: 10049760
[TBL] [Abstract][Full Text] [Related]
13. Anti-cancer effect of oncolytic adenovirus-armed shRNA targeting MYCN gene on doxorubicin-resistant neuroblastoma cells.
Li Y; Zhuo B; Yin Y; Han T; Li S; Li Z; Wang J
Biochem Biophys Res Commun; 2017 Sep; 491(1):134-139. PubMed ID: 28711493
[TBL] [Abstract][Full Text] [Related]
14. Co-transfection of MDR1 and MRP antisense RNAs abolishes the drug resistance in multidrug-resistant human lung cancer cells.
Gao Z; Gao Z; Fields JZ; Boman BM
Anticancer Res; 1998; 18(4C):3073-6. PubMed ID: 9713512
[TBL] [Abstract][Full Text] [Related]
15. [Modulation of human small cell lung cancer cell line GLC4/ADR multidrug resistance in the inhibition of multidrug resistance-associated protein and its antisense].
Peng X; Feng F; Zhang W
Zhonghua Zhong Liu Za Zhi; 2001 Sep; 23(5):355-8. PubMed ID: 11810759
[TBL] [Abstract][Full Text] [Related]
16. ABC transporters and neuroblastoma.
Yu DM; Huynh T; Truong AM; Haber M; Norris MD
Adv Cancer Res; 2015; 125():139-70. PubMed ID: 25640269
[TBL] [Abstract][Full Text] [Related]
17. Multidrug resistance-associated protein gene expression and drug sensitivity in human lung cancer cells.
Narasaki F; Oka M; Fukuda M; Ikeda K; Terashi K; Takatani H; Nakamura T; Soda H; Kohno S
Anticancer Res; 1997; 17(5A):3493-7. PubMed ID: 9413193
[TBL] [Abstract][Full Text] [Related]
18. ABCC multidrug transporters in childhood neuroblastoma: clinical and biological effects independent of cytotoxic drug efflux.
Henderson MJ; Haber M; Porro A; Munoz MA; Iraci N; Xue C; Murray J; Flemming CL; Smith J; Fletcher JI; Gherardi S; Kwek CK; Russell AJ; Valli E; London WB; Buxton AB; Ashton LJ; Sartorelli AC; Cohn SL; Schwab M; Marshall GM; Perini G; Norris MD
J Natl Cancer Inst; 2011 Aug; 103(16):1236-51. PubMed ID: 21799180
[TBL] [Abstract][Full Text] [Related]
19. Expression of the multidrug resistance-associated protein (MRP) gene correlates with amplification and overexpression of the N-myc oncogene in childhood neuroblastoma.
Bordow SB; Haber M; Madafiglio J; Cheung B; Marshall GM; Norris MD
Cancer Res; 1994 Oct; 54(19):5036-40. PubMed ID: 7923112
[TBL] [Abstract][Full Text] [Related]
20. Characterization of multidrug transporter-mediated efflux of avermectins in human and mouse neuroblastoma cell lines.
Dalzell AM; Mistry P; Wright J; Williams FM; Brown CD
Toxicol Lett; 2015 Jun; 235(3):189-98. PubMed ID: 25865432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
